0001104659-20-081471.txt : 20200706
0001104659-20-081471.hdr.sgml : 20200706
20200706194559
ACCESSION NUMBER: 0001104659-20-081471
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200701
FILED AS OF DATE: 20200706
DATE AS OF CHANGE: 20200706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Crowley John F
CENTRAL INDEX KEY: 0001400973
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 201014901
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 662-2000
MAIL ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
FORMER COMPANY:
FORMER CONFORMED NAME: AMICUS THERAPEUTICS INC
DATE OF NAME CHANGE: 20020729
4
1
a4.xml
4
X0306
4
2020-07-01
0
0001178879
AMICUS THERAPEUTICS, INC.
FOLD
0001400973
Crowley John F
C/O AMICUS THERAPEUTICS, INC.
1 CEDAR BROOK DRIVE
CRANBURY
NJ
08512
1
1
0
0
Chairman & CEO
Common Stock
2020-07-01
4
M
0
20000
5.96
A
920023
D
Common Stock
2020-07-01
4
S
0
39655
15.48
D
880368
D
Common Stock
64895
I
By Trust
Stock Options (right to buy)
5.96
2020-07-01
4
M
0
20000
0
D
2021-01-19
Common Stock
20000
83975
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.05 to $15.69 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
All of these options were fully vested and exercisable as of July 1, 2020.
In addition to the reported transactions, Mr. Crowley also has approximately 1.56 million options outstanding and exercisable at various strike prices.
/s/ Christian Formica, Attorney-in-Fact
2020-07-06